Condition

Clinically Significant Prostate Cancer

ClinicalTrials.gov condition label

Clinical trials5

Recruiting4

Common interventions6

Lead sponsors shown5

Clinical trials

5 shown

Transperineal Versus Transrectal Cognitive Fusion Prostate BiopsyNCT07710807 · 2026-06-01

RECRUITING

Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active SurveillanceNCT07168616 · 2025-09-01

RECRUITING

Multimodal Imaging and Digital Pathology for Prostate Cancer PredictionNCT07614256 · 2025-05-30

RECRUITING

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate CancerNCT07492927 · 2021-03-12

RECRUITING

Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal BiopsyNCT03044197 · 2017-07-25

COMPLETED

Common interventions

Ga-68 PSMA11 PET/CTDIAGNOSTIC_TEST1MRI/ultrasound transperineal prostate biopsyDEVICE1No Intervention: Observational CohortOTHER1Transperineal Cognitive Fusion Prostate BiopsyPROCEDURE1Transrectal Cognitive Fusion Prostate BiopsyPROCEDURE1transrectal ultrasound-guided prostate biopsyDEVICE1

Leading sponsors

Ankara Etlik City Hospital1Guangxi Medical University1Istanbul University - Cerrahpasa1The University of Texas Medical Branch, Galveston1Xijing Hospital1

Trial status mix

RECRUITING4

COMPLETED1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.